Orlistat

Overview

The Patient Information Leaflet for products containing Orlistat from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. To contact Teva's Medical Information Service email: medinfo@tevauk.com or telephone: 0207 540 7117.

Available as

Capsules

Teva medicines containing Orlistat

Name & Details

Packaging

Strength

Form

Pack Size

FAQs

- Pack type: PP
- PIP code: 116-8558
- Product licence number: 00289/1680
- Product code: 231-10-01408
- Product classification: POM
- Categories: Orlistat
Enlarge image

Colours and sizes may differ from the example.
Medicine supporting documentation
- Patient Information Leaflet
  View Document
- Summary Of Product Characteristics
  View Document

Key

GB

Great Britain
NI

Northern Ireland
3rd party Product
Discontinued
Calendar Patient Pack
General Sales List
Pharmacy Only
Patient Pack
Prescription Only Medicine

Teva UK Limited also distributes some third party products within our portfolio, these products are identified with a 3rd party icon. For further information on these third party products, please contact the relevant Marketing Authorisation (MA) holder. If you require further assistance, you can contact our Medical Information Service by email medinfo@tevauk.com, or call 0207 5407117.

Reporting of side effects - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the Package Leaflet.
You can report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side events you can help provide more information on the safety of this medicine. Side effects should also be reported to Teva using the Reporting Side Effects Form or email uk.safety@tevauk.com or telephone 0207 540 7117.

$(document).ready(function () { $(this).find(".foreign_link").click(onLinkClick); });

Date of preparation: April 2023
D: COB-GB-NP-00112 (V1.0) / T: COB-GB-NP-00102 (V1.0) / M: COB-GB-NP-00103 (V1.0)

Date of preparation: April 2023
D: COB-GB-00016 (V1.0) / T: COB-GB-00014 (V1.0) / M: COB-GB-00015 (V1.0)

Date of preparation: April 2023
D: COB-GB-NP-00104 (V1.0) / T: COB-GB-NP-00105 (V1.0) / M: COB-GB-NP-00106 (V1.0)

Orlistat

Overview

Teva's Product List

You Are Now Leaving This Website